News

VIB Discovery Sciences
17 June 2019
Theme of new VIBTimes is: VIB Discovery Sciences
On the importance of being translational: Oncology biotech
17 June 2019
The very first model in the field of immuno-oncology is clarified by Jean Feyen, chief scientific officer at Oxurion and Bruno Dombrecht, who joined the Discovery Sciences team in2018 and specializes in therapeutic biologics.
On the importance of being translational: Patient-driven therapeutics
17 June 2019
Our second example leads us into the field of neurology and peripheral neuropathies. More specifically to Charcot-Marie-Tooth disease (CMT), an incurable progressive weakening and atrophy of distal limb muscles.
A quest for new products
17 June 2019
In his research, Lieven aims at identifying mechanisms that link cell division with environmental stimuli. Both Anne Helfer and Lieven De Veylder are engaged in a quest for new products.
A single gut enterotype linked to both inflammatory bowel disease and depression
17 June 2019
In 2012, Professor Jeroen Raes (VIB-KU Leuven Center for Microbiology) launched the Flemish Gut Flora Project. Today, their results on the high prevalence of this particular enterotype across multiple diagnoses are published in Nature Microbiology.
VIB scientist Wout Boerjan elected as EMBO Member
11 June 2019
EMBO membership is one of most highly prized recognitions of excellence in the life sciences for individual researchers. A deserved recognition for Prof. Wout Boerjan (VIB-UGent Center for Plant Systems Biology).
ONCURIOUS NV Receives Project Grant from VLAIO to Progress its Pipeline of Next Generation Cancer Immunotherapies
11 June 2019
ONCURIOUS NV today announces that it has received from Flanders Innovation and Entrepreneurship (VLAIO) a project grant of close to €1 million to support the further pre-clinical development of its pipeline of next generation cancer immunotherapies
Introducing VIB Discovery Sciences: an interview with Jérôme Van Biervliet
10 June 2019
The ‘VIB Discovery Sciences’ unit is embedded in VIB’s Innovation & Business team and focuses on making specific expertise available to promising projects in VIB labs that are amenable to translation.
Duvel Moortgat opens scientific pilot brewery and presents BSSH Awards to Sir Paul Nurse, 2001 Nobel Laureate
7 June 2019
On June 7th 2019, Duvel Moortgat and KU Leuven host the Brewing Science Serves Health (BSSH) awards along with the opening of a new pilot brewery and research laboratory.
Salty diet reduces tumor growth by tackling immune cells
5 June 2019
A study by a research team led by Markus Kleinewietfeld (VIB-UHasselt) shows that high salt intake inhibits tumor growth in mice. The effect seems to be due to a change in function of certain immune cells which play a critical role in cancer immunity.
From VIB conference to high-impact publication
3 June 2019
As a direct result of the ‘Revolutionizing Next-Generation Sequencing’ conference, organized by the VIB conferences team and held at Antwerp, Belgium, 25-26 March 2019, a paper has been published in the prestigious journal Genome Biology.
Towards a safer treatment for leukemia
29 May 2019
An international team of researchers at VIB-KU Leuven, Belgium, the UK Dementia Institute and the Children’s Cancer Institute, Australia, have found a safer treatment for a specific type of leukemia.
Scientists (dis)solve a century-long mystery to treat asthma and airway inflammation
23 May 2019
Belgian research groups from the VIB, Ghent University, Ghent University Hospital, and the biotech company argenx have solved a century-long puzzle about the presence of protein crystals in asthma.
Preventing cell death as novel therapeutic strategy for rheumatoid arthritis
10 May 2019
A study by research groups from the University of Cologne, VIB, Ghent University, the Βiomedical Sciences Research Center ‘Alexander Fleming’ in Athens & the University of Tokyo identified a new molecular mechanism causing rheumatoid arthritis.
Detailed brain map uncovers hidden immune cells that may be involved in neurodegenerative disorders
6 May 2019
A team led by Kiavash Movahedi (VIB-VUB) has developed a comprehensive cell atlas of the brain's immune compartment. This revealed not only the striking diversity of brain macrophages, but also found microglia where they were not expected

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 Next»

Get news updates:

Email updates
Follow us on Twitter
Like us on Facebook
RSS